These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2214787)

  • 1. Preferential nuclear binding of estrogen in the formalin-fixed rat uterus.
    Campbell PS; Swanson KA
    J Steroid Biochem; 1990 Aug; 36(6):703-5. PubMed ID: 2214787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
    Clark JH; Markaverich B; Upchurch S; Eriksson H; Hardin JW
    Adv Exp Med Biol; 1979; 117():17-46. PubMed ID: 474276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a unique population of unfilled estrogen-binding sites associated with the nuclear fraction of immature rat uteri.
    Carlson RA; Gorski J
    Endocrinology; 1980 Jun; 106(6):1776-85. PubMed ID: 7371593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen decreases the estradiol induced progesterone receptors by interfering with nuclear estrogen receptor accumulation.
    Castellano-Díaz E; González-Quijano MI; Limiñana JM; Díaz-Chico BN
    J Steroid Biochem; 1989 Jul; 33(1):133-9. PubMed ID: 2761261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between estrogen receptor and subcellular structures of target cells: nuclear localization of unoccupied receptor and its modification induced by estradiol.
    Puca GA; Medici N; Armetta I; Nigro V; Moncharmont B; Molinari AM
    Ann N Y Acad Sci; 1986; 464():168-89. PubMed ID: 3524348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange.
    Markaverich BM; Williams M; Upchurch S; Clark JH
    Endocrinology; 1981 Jul; 109(1):62-9. PubMed ID: 7238414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrete early changes in cellular subpopulations of rat uterine and anterior pituitary estrogen receptors in response to acute exposure to exogenous estradiol.
    Copland JA; Smanik EJ; Muldoon TG
    J Steroid Biochem; 1987 Jun; 26(6):723-31. PubMed ID: 3613573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of 5-alpha-dihydroprogesterone on nuclear estrogen receptor binding of the anterior pituitary and uterus in the rat.
    Fuentes MA; Muldoon TG; Mahesh VB
    Neuroendocrinology; 1990 Sep; 52(3):213-20. PubMed ID: 2120603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the nuclear localization of [3H]estradiol in rat uterine tissue in vitro.
    Campbell PS; Albright CW; Wilson JH; Bridges RR
    J Steroid Biochem; 1989 May; 32(5):681-7. PubMed ID: 2739408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
    Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
    Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophils as the source of uterine nuclear type II estrogen binding sites.
    Lyttle CR; Medlock KL; Sheehan DM
    J Biol Chem; 1984 Mar; 259(5):2697-700. PubMed ID: 6698988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of different cytoplasmic and nuclear estrogen receptors appearing with continuous hormonal exposure.
    Jakesz R; Kasid A; Greene G; Lippman ME
    J Biol Chem; 1983 Oct; 258(19):11807-13. PubMed ID: 6619145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of in vivo estradiol administration on availability of rat uterine nuclear acceptor in measured in vitro.
    Chuknyiska RS; Haji M; Foote RH; Roth GS
    Endocrinology; 1984 Aug; 115(2):836-8. PubMed ID: 6745185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
    Ruh TS; Baudendistel LJ
    Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitation and inhibition of the estrogen-induced luteinizing hormone surge in the rat by progesterone: effects on cytoplasmic and nuclear estrogen receptors in the hypothalamus-preoptic area, pituitary, and uterus.
    Attardi B
    Endocrinology; 1981 Apr; 108(4):1487-96. PubMed ID: 7472278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine type II estrogen-binding sites are not of eosinophil origin.
    Markaverich BM; Roberts RR; Alejandro MA; Clark JH
    J Biol Chem; 1986 Jan; 261(1):142-6. PubMed ID: 3941067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of low dose continuous exposure to estradiol on the estrogen receptor (type I) and nuclear type II sites.
    Markaverich BM; Roberts RR; Alejandro M; Clark JH
    Endocrinology; 1984 Mar; 114(3):814-20. PubMed ID: 6697964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased estrogenic stimulation of RNA polymerase II in aged rat uteri is apparently due to reduced nuclear binding of receptor-estradiol complexes.
    Chuknyiska RS; Roth GS
    J Biol Chem; 1985 Jul; 260(15):8661-3. PubMed ID: 4019445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen dependent induction of low affinity binding sites in the nuclear fraction of rat uterus.
    De Hertogh R; Ekka E; Vanderheyden I
    J Steroid Biochem; 1986 Jun; 24(6):1171-7. PubMed ID: 3736044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modulator which converts activated estrogen receptor to a biologically inactive aggregated form.
    Nishizawa Y; Maeda Y; Noma K; Sato B; Matsumoto K; Yamamura Y
    Endocrinology; 1981 Nov; 109(5):1463-72. PubMed ID: 6795027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.